Resultados de la búsqueda 281-290 of 3310 for total protein

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    In general terms, scientists will study the cells, DNA, RNA, and proteins ... complete a written questionnaire in English either independently or with ...

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    Subjects in the Biobank will provide samples of excess breast tissue, complete a health questionnaire, and allow access to medical records now and in the future ...

  3. Hematología - Ensayos clínicos - Mayo Clinic

    ... protein CMVpp65. Cohort 1 includes blood collections for in vitro studies which are a component of NIH-funded Project 3 within the Mayo Clinic Pancreatic ...

  4. The world's best hospital - Mayo Clinic

    Mayo Clinic is the No. 1 hospital in the world., with campuses in Arizona, Florida, and Minnesota.

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... protein CMVpp65. Cohort 1 includes blood collections for in vitro studies which are a component of NIH-funded Project 3 within the Mayo Clinic Pancreatic ...

  6. Transplant Center de Mayo Clinic - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation ...

  7. Transplant Center de Mayo Clinic - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    ... protein CMVpp65. Cohort 1 includes blood collections for in vitro studies which are a component of NIH-funded Project 3 within the Mayo Clinic Pancreatic ...

  9. Hematología - Ensayos clínicos - Mayo Clinic

    ... protein CMVpp65. Cohort 1 includes blood collections for in vitro studies which are a component of NIH-funded Project 3 within the Mayo Clinic Pancreatic ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab ...